STOCK TITAN
  1. Home
  2. NLBIF

NLBIF (NLBIF) Stock Price, News & Analysis

NLBIF
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for NLBIF, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

management
—

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

—

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

management
—

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

management
—

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

—

Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

—

Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

NLBIF has 7 recent news articles. Key topics include management. View all NLBIF news →

SEC Filings

View All

No SEC filings available for NLBIF.